This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 117/20/2599    most recent CIRCULATIONAHA.107.717892v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chami, H. A. Articles by Gottlieb, D. J. Search for Related Content PubMed PubMed Citation Articles by Chami, H. A. Articles by Gottlieb, D. J. Pubmed/NCBI databases Medline Plus Health Information Sleep Apnea Related Collections Other heart failure Hypertrophy Epidemiology Related Article

(Circulation. 2008;117:2599-2607.)
© 2008 American Heart Association, Inc.

Epidemiology

Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing

The Sleep Heart Health Study

Hassan A. Chami, MD, MSc; Richard B. Devereux, MD; John S. Gottdiener, MD; Reena Mehra, MD, MS; Mary J. Roman, MD; Emelia J. Benjamin, MD, ScM; Daniel J. Gottlieb, MD, MPH

From the Departments of Medicine at Boston University School of Medicine (H.A.C., E.J.B., D.J.G.) and VA Boston Healthcare System (H.A.C., D.J.G.), Boston, Mass; Weill Cornell Medical College (R.B.D., M.J.R.), New York, NY; University of Maryland Hospital (J.S.G.), Baltimore, Md; Case Medical School (R.M.), University Hospitals of Cleveland, Cleveland, Ohio; and the National Heart, Lung, and Blood Institute’s Framingham Heart Study (E.J.B.), Framingham, Mass.

Reprint requests to Hassan A. Chami, MD, MSc, The Pulmonary Center, Boston University School of Medicine, 715 Albany St, R-304, Boston, MA 02118-2394. E-mail hchami{at}bu.edu

Received August 13, 2007; accepted March 3, 2008.

Background— Whether sleep-disordered breathing (SDB) is a risk factor for left ventricular (LV) hypertrophy and dysfunction is controversial. We assessed the relation of SDB to LV morphology and systolic function in a community-based sample of middle-aged and older adults.

Methods and Results— The present study was a cross-sectional observational study of 2058 Sleep Heart Health Study participants (mean age 65±12 years; 58% women; 44% ethnic minorities) who had technically adequate echocardiograms. A polysomnographically derived apnea-hypopnea index (AHI) and hypoxemia index (percent of sleep time with oxyhemoglobin saturation <90%) were used to quantify SDB severity. LV mass index was significantly associated with both AHI and hypoxemia index after adjustment for age, sex, ethnicity, study site, body mass index, current and prior smoking, alcohol consumption, systolic blood pressure, antihypertensive medication use, diabetes mellitus, and prevalent myocardial infarction. Adjusted LV mass index was 41.3 (SD 9.90) g/m^2.7 in participants with AHI <5 (n=957) and 44.1 (SD 9.90) g/m^2.7 in participants with AHI 30 (n=84) events per hour. Compared with participants with AHI <5, those with AHI 30 had an adjusted odds ratio of 1.78 (95% confidence interval 1.14 to 2.79) for LV hypertrophy. A higher AHI and higher hypoxemia index were also associated with larger LV diastolic dimension and lower LV ejection fraction, with a trend toward lower LV fractional shortening. LV wall thickness was significantly associated with the hypoxemia index but not with AHI. Left atrial diameter was not associated with either SDB measure.

Conclusions— In a community-based cohort, SDB is associated with echocardiographic evidence of increased LV mass and reduced LV systolic function.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 2567-2569. [Extract] [Full Text]